Metaspa-XL 25 Tablet ER
Marketer
Spansa Pharmaceuticals Pvt. Ltd.
Salt Composition
Metoprolol Succinate (23.75mg)
Overview Metaspa-XL 25 Tablet ER
Extended-release Metoprolol Succinate 25 mg tablets are beta-blockers used to manage hypertension, angina pectoris, and cardiac arrhythmias. This medication also helps prevent migraines, recurrent heart attacks, and stroke. Dosage and frequency depend on the condition being treated and its severity; it may be prescribed alone or in combination with other drugs. The medication can be taken with or without food, but consistent daily timing maximizes effectiveness. Full therapeutic benefits may take several weeks to appear, and continuous use may be necessary. Discontinuing treatment can worsen underlying conditions, even if symptoms are absent. Common, usually mild and transient, side effects include fatigue, cephalgia, depression, diarrhea, skin rash, bradycardia, dizziness, and nausea. Less frequent side effects may include dyspnea or hypotension. Gradual dose escalation minimizes adverse events. Report persistent or bothersome side effects to your physician. Prior to initiating therapy, inform your doctor of any liver dysfunction. This medication is contraindicated in patients with bradycardia, severe peripheral vascular disease, severe congestive heart failure, or hypotension. Pregnant or lactating individuals should consult their physician before use. A physician's assessment is crucial to determine suitability. Regular blood pressure monitoring ensures optimal therapeutic response. Alcohol consumption should be avoided due to potential exacerbation of adverse effects.
Uses of Metaspa-XL 25 Tablet ER
Managing angina pectoris (chest pain from heart disease)|Correcting cardiac arrhythmias|Reducing the risk of myocardial infarction|Controlling hypertension (high blood pressure)|Preventing migraine headaches
Major Benefits of Metaspa-XL 25 Tablet ER:
Follow your doctor's instructions precisely regarding dosage and treatment length for Metaspa-XL 25 Tablet ER. Swallow the tablet whole; do not crush, chew, or break it. This extended-release medication can be taken with or without food, but consistent timing is recommended. Minimize consumption of high-fat foods like olive oil, nuts (including Brazil nuts), dark chocolate, butter, and fatty meats while using Metaspa-XL 25 Tablet ER.
Common Side effects of Metaspa-XL 25 Tablet ER:
- Tiredness
- Dizziness
- Depression
- Breathlessness
- Headache
- Slow heart rate
- Nausea
- Rash
- Diarrhea
- Hypotension (low blood pressure)
How to use Metaspa-XL 25 Tablet ER:
Follow your doctor's instructions precisely regarding dosage and treatment length for Metaspa-XL 25 Tablet ER. Ingest the tablet whole; do not chew, crush, or divide it. This medication can be taken with or without food, but consistency in timing is recommended. Minimize consumption of high-fat foods, including olive oil, nuts (like Brazil nuts), dark chocolate, butter, and red meat, while taking Metaspa-XL 25 Tablet ER.
How Metaspa-XL 25 Tablet ER works:
Extended-release Metaspa-XL 25mg tablets are a cardioselective beta-adrenergic blocker. They reduce heart rate and enhance the heart's pumping efficiency, providing sustained blood circulation support.
SAFETY ADVICE
AlcoholUNSAFE
Combining alcohol and Metaspa-XL 25 Tablet ER is not advisable.
PregnancyCONSULT YOUR DOCTOR
The use of Metaspa-XL 25 Extended-Release tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the potential advantages against any possible risks prior to prescribing. Seek medical advice before taking this medication.
Breast feedingSAFE IF PRESCRIBED
Extended-release Metaspa-XL 25mg tablets are likely safe for breastfeeding mothers. Available evidence from human studies indicates minimal infant risk associated with this medication.
DrivingUNSAFE
Extended-release Metaspa-XL 25mg tablets can cause drowsiness, blurred vision, and dizziness. Refrain from driving if you experience these effects.
KidneySAFE IF PRESCRIBED
Extended-release Metaspa-XL 25 mg tablets are considered safe for patients with impaired renal function. No dosage modification is necessary for Metaspa-XL 25 mg extended-release tablets in this population.
LiverCAUTION
Extended-release Metaspa-XL 25 mg tablets require careful administration for individuals with hepatic impairment. Dosage modification of Metaspa-XL 25 mg extended-release tablets may be necessary. Physician consultation is advised.
What if you forget to take Metaspa-XL 25 Tablet ER :
Should you forget a Metaspa-XL 25 Tablet ER dose, take it promptly. Nevertheless, if your next dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Metaspa-XL 25 Tablet ER
| Label | Value |
|---|---|
| Chemical Type | Alcohols and Phenols |
| Developing Habits | No. |
| Treatment Category | Heart |


